Feature
Redefining Success in Hypotony Treatment
-
By
February 10, 2026
-
10 min
-
1
Chronic ocular hypotony leads to risk of irreversible vision damage.
-
2
HPMC has shown potential in restoring eye structure and vision.
-
3
The first patient improved from 1/60 to 6/12 vision.
-
4
Measurement of axial length is crucial in managing hypotony.
-
5
A structured governance process is needed for new treatment approaches.
-
Chronic ocular hypotony presents a complex challenge for ophthalmologists, often leading to irreversible damage if not addressed properly. Dr. Harry Petrushkina from Moorfields Hospital discusses innovative findings from a study on intravitreal hydroxypropylmethylcellulose (HPMC), revealing a potential method to restore vision and eye structure. By focusing on biomechanical principles and defining treatment endpoints, this approach showed significant visual improvements in patients, hinting at a new direction in managing this previously difficult condition.
-
1
Chronic ocular hypotony leads to risk of irreversible vision damage.
-
2
HPMC has shown potential in restoring eye structure and vision.
-
3
The first patient improved from 1/60 to 6/12 vision.
-
4
Measurement of axial length is crucial in managing hypotony.
-
5
A structured governance process is needed for new treatment approaches.
Listen Tab content
